series-b
Stage
2
Investors
About
Gritstone Oncology is a biotechnology company developing immunotherapies that leverage multi-specific antibodies to target tumor cells and stimulate the patient’s immune system to fight cancers such as lung, gastric, esophageal, head and neck, and cervical cancers.
Explore Gritstone Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.